{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:28:58Z","timestamp":1767598138522,"version":"3.37.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021077","name":"Vice Chancellor for Research and Technology of Kerman University of Medical Sciences","doi-asserted-by":"crossref","award":["980010000","980010000","980010000","980010000"],"award-info":[{"award-number":["980010000","980010000","980010000","980010000"]}],"id":[{"id":"10.13039\/501100021077","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09383-y","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T16:01:26Z","timestamp":1716652886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Platelet microparticles influence gene expression and modulate biological activities of chronic myeloid leukemia cells (K562)"],"prefix":"10.1007","volume":"51","author":[{"given":"Fariba","family":"Nikravesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roohollah","family":"Mirzaee Khalilabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Farsinejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajar","family":"Mardani Valandani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"issue":"3","key":"9383_CR1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/ajh.25011","volume":"93","author":"E Jabbour","year":"2018","unstructured":"Jabbour E, Kantarjian H (2018) Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring. Am J Hematol 93(3):442\u2013459. https:\/\/doi.org\/10.1002\/ajh.25011","journal-title":"Am J Hematol"},{"issue":"5","key":"9383_CR2","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41375-021-01238-w","volume":"35","author":"Y-C Hsieh","year":"2021","unstructured":"Hsieh Y-C, Kirschner K, Copland M (2021) Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape. Leukemia 35(5):1229\u20131242. https:\/\/doi.org\/10.1038\/s41375-021-01238-w","journal-title":"Leukemia"},{"key":"9383_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100825","volume":"49","author":"AEG Osman","year":"2021","unstructured":"Osman AEG, Deininger MW (2021) Chronic myeloid leukemia: modern therapies, current challenges and future directions. Blood Rev 49:100825. https:\/\/doi.org\/10.1016\/j.blre.2021.100825","journal-title":"Blood Rev"},{"issue":"9","key":"9383_CR4","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/ajh.26642","volume":"97","author":"E Jabbour","year":"2022","unstructured":"Jabbour E, Kantarjian H (2022) Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring. Am J Hematol 97(9):1236\u20131256. https:\/\/doi.org\/10.1002\/ajh.26642","journal-title":"Am J Hematol"},{"issue":"10","key":"9383_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1609324","volume":"376","author":"A Hochhaus","year":"2017","unstructured":"Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP et al (2017) Long-term outcomes of imatinib treatment for chronic myeloid leukemia. N Engl J Med 376(10):917\u2013927. https:\/\/doi.org\/10.1056\/NEJMoa1609324","journal-title":"N Engl J Med"},{"issue":"4","key":"9383_CR6","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","volume":"34","author":"A Hochhaus","year":"2020","unstructured":"Hochhaus A, Baccarani M, Silver RT, Schiffer C, Apperley JF, Cervantes F et al (2020) European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia 34(4):966\u2013984. https:\/\/doi.org\/10.1038\/s41375-020-0776-2","journal-title":"Leukemia"},{"issue":"1","key":"9383_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-022-01309-0","volume":"15","author":"V Garc\u00eda-Guti\u00e9rrez","year":"2022","unstructured":"Garc\u00eda-Guti\u00e9rrez V, Breccia M, Jabbour E, Mauro M, Cortes JE (2022) A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase. J Hematol Oncol 15(1):90. https:\/\/doi.org\/10.1186\/s13045-022-01309-0","journal-title":"J Hematol Oncol"},{"issue":"1","key":"9383_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12935-017-0460-4","volume":"17","author":"L Repsold","year":"2017","unstructured":"Repsold L, Pool R, Karodia M, Tintinger G, Joubert AM (2017) An overview of the role of platelets in angiogenesis, apoptosis and autophagy in chronic myeloid leukaemia. Cancer Cell Int 17(1):89. https:\/\/doi.org\/10.1186\/s12935-017-0460-4","journal-title":"Cancer Cell Int"},{"issue":"2","key":"9383_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/cancers11020240","volume":"11","author":"PT Huong","year":"2019","unstructured":"Huong PT, Nguyen LT, Nguyen X-B, Lee SK, Bach D-H (2019) The Role of platelets in the tumor-microenvironment and the drug resistance of cancer cells. Cancers [Internet] 11(2):240","journal-title":"Cancers [Internet]"},{"issue":"5","key":"9383_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1182\/blood-2017-05-786327","volume":"130","author":"E Boilard","year":"2017","unstructured":"Boilard E (2017) Platelet-derived nanomedicine targets cancer. Blood 130(5):561\u2013562. https:\/\/doi.org\/10.1182\/blood-2017-05-786327","journal-title":"Blood"},{"key":"9383_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fcvm.2018.00013","volume":"5","author":"S Lazar","year":"2018","unstructured":"Lazar S, Goldfinger LE (2018) Platelet microparticles and miRNA transfer in cancer progression: many targets, modes of action, and effects across cancer stages. Front Cardiovasc Med 5:13. https:\/\/doi.org\/10.3389\/fcvm.2018.00013","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"9383_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/cancers15020350","volume":"15","author":"A Contursi","year":"2023","unstructured":"Contursi A, Fullone R, Szklanna-Koszalinska P, Marcone S, Lanuti P, Taus F et al (2023) Tumor-educated platelet extracellular vesicles: proteomic profiling and crosstalk with colorectal cancer cells. Cancers [Internet] 15(2):350","journal-title":"Cancers [Internet]"},{"issue":"1","key":"9383_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12929-023-00972-w","volume":"30","author":"T Burnouf","year":"2023","unstructured":"Burnouf T, Chou M-L, Lundy DJ, Chuang E-Y, Tseng C-L, Goubran H (2023) Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery. J Biomed Sci 30(1):79. https:\/\/doi.org\/10.1186\/s12929-023-00972-w","journal-title":"J Biomed Sci"},{"issue":"2","key":"9383_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.15605\/jafes.038.02.03","volume":"38","author":"HA Indana","year":"2023","unstructured":"Indana HA, Puspitawati I, Mayasari DS, Hartopo AB (2023) Association of acute hyperglycemia and diabetes mellitus with amount of platelets derived microparticles during acute myocardial infarction. J ASEAN Fed Endocr Soc 38(2):35\u201340. https:\/\/doi.org\/10.15605\/jafes.038.02.03","journal-title":"J ASEAN Fed Endocr Soc"},{"issue":"18","key":"9383_CR15","doi-asserted-by":"publisher","first-page":"10524","DOI":"10.3390\/ijms231810524","volume":"23","author":"LM Lugo-Gavidia","year":"2022","unstructured":"Lugo-Gavidia LM, Nolde JM, Carnagarin R, Burger D, Chan J, Robinson S et al (2022) Association of circulating platelet extracellular vesicles and pulse wave velocity with cardiovascular risk estimation. Int J Mol Sci 23(18):10524","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9383_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s13287-021-02561-w","volume":"12","author":"Y Tang","year":"2021","unstructured":"Tang Y, Li J, Wang W, Chen B, Chen J, Shen Z et al (2021) Platelet extracellular vesicles enhance the proangiogenic potential of adipose-derived stem cells in vivo and in vitro. Stem Cell Res Ther 12(1):497. https:\/\/doi.org\/10.1186\/s13287-021-02561-w","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"9383_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/10641963.2018.1510941","volume":"41","author":"Y Yang","year":"2019","unstructured":"Yang Y, Luo H, Liu S, Zhang R, Zhu X, Liu M et al (2019) Platelet microparticles-containing miR-4306 inhibits human monocyte-derived macrophages migration through VEGFA\/ERK1\/2\/NF-\u03baB signaling pathways. Clin Exp Hypertens 41(5):481\u2013491. https:\/\/doi.org\/10.1080\/10641963.2018.1510941","journal-title":"Clin Exp Hypertens"},{"issue":"9","key":"9383_CR18","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1080\/10428194.2016.1272682","volume":"58","author":"LF Peterson","year":"2017","unstructured":"Peterson LF, Lo M-C, Liu Y, Giannola D, Mitrikeska E, Donato NJ et al (2017) Induction of p53 suppresses chronic myeloid leukemia. Leuk Lymphoma 58(9):2165\u20132175. https:\/\/doi.org\/10.1080\/10428194.2016.1272682","journal-title":"Leuk Lymphoma"},{"issue":"16","key":"9383_CR19","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1080\/07391102.2019.1691661","volume":"38","author":"E Chamani","year":"2020","unstructured":"Chamani E, Rezaei Z, Dastjerdi K, Javanshir S, Khorsandi K, Mohammadi GA (2020) Evaluation of some genes and proteins involved in apoptosis on human chronic myeloid leukemia cells (K562 cells) by datura innoxia leaves aqueous extract. J Biomol Struct Dyn 38(16):4838\u20134849. https:\/\/doi.org\/10.1080\/07391102.2019.1691661","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"9383_CR20","doi-asserted-by":"publisher","first-page":"17990","DOI":"10.1038\/s41598-022-21009-6","volume":"12","author":"W Liu","year":"2022","unstructured":"Liu W, Zhu X, Tang L, Shen N, Cheng F, Zou P et al (2022) ACSL1 promotes imatinib-induced chronic myeloid leukemia cell senescence by regulating SIRT1\/p53\/p21 pathway. Sci Rep 12(1):17990. https:\/\/doi.org\/10.1038\/s41598-022-21009-6","journal-title":"Sci Rep"},{"issue":"1","key":"9383_CR21","doi-asserted-by":"publisher","first-page":"24692","DOI":"10.3402\/jev.v3.24692","volume":"3","author":"MT Aatonen","year":"2014","unstructured":"Aatonen MT, \u00d6hman T, Nyman TA, Laitinen S, Gr\u00f6nholm M, Siljander PRM (2014) Isolation and characterization of platelet-derived extracellular vesicles. J Extracell Vesicles 3(1):24692. https:\/\/doi.org\/10.3402\/jev.v3.24692","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"9383_CR22","doi-asserted-by":"publisher","first-page":"2304963","DOI":"10.1080\/2162402X.2024.2304963","volume":"13","author":"M Zhou","year":"2024","unstructured":"Zhou M, Feng Y, Zhang X, Chen J, Yao N, Fu S et al (2024) Platelet-derived microparticles adoptively transfer integrin \u03b23 to promote antitumor effect of tumor-infiltrating T cells. OncoImmunology 13(1):2304963. https:\/\/doi.org\/10.1080\/2162402X.2024.2304963","journal-title":"OncoImmunology"},{"issue":"1","key":"9383_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-015-0327-z","volume":"14","author":"H Liang","year":"2015","unstructured":"Liang H, Yan X, Pan Y, Wang Y, Wang N, Li L et al (2015) MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3. Mol Cancer 14(1):58. https:\/\/doi.org\/10.1186\/s12943-015-0327-z","journal-title":"Mol Cancer"},{"key":"9383_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-023-04734-y","author":"MH Ashoub","year":"2023","unstructured":"Ashoub MH, Salavatipour MS, Kasgari FH, Valandani HM, Khalilabadi RM (2023) Extracellular microvesicles: biologic properties, biogenesis, and applications in leukemia. Mol Cell Biochem. https:\/\/doi.org\/10.1007\/s11010-023-04734-y","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"9383_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.beha.2009.07.007","volume":"22","author":"M Rohrbacher","year":"2009","unstructured":"Rohrbacher M, Hasford J (2009) Epidemiology of chronic myeloid leukaemia (CML). Best Pract Res Clin Haematol 22(3):295\u2013302. https:\/\/doi.org\/10.1016\/j.beha.2009.07.007","journal-title":"Best Pract Res Clin Haematol"},{"key":"9383_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JBM.S187005","volume":"10","author":"S Nomura","year":"2018","unstructured":"Nomura S, Ito T, Satake A, Ishii K (2018) Assessment of soluble cytotoxic T lymphocyte-associated antigen-4, transforming growth factor \u03b21, and platelet-derived microparticles during dasatinib therapy for patients with chronic myelogenous leukemia. J Blood Med 10:1\u20138. https:\/\/doi.org\/10.2147\/JBM.S187005","journal-title":"J Blood Med"},{"issue":"1","key":"9383_CR27","doi-asserted-by":"publisher","first-page":"118886","DOI":"10.1016\/j.bbamcr.2020.118886","volume":"1868","author":"M Vismara","year":"2021","unstructured":"Vismara M, Zar\u00e0 M, Negri S, Canino J, Canobbio I, Barbieri SS et al (2021) Platelet-derived extracellular vesicles regulate cell cycle progression and cell migration in breast cancer cells. Biochim Biophys Acta (BBA) Mol Cell Res 1868(1):118886. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118886","journal-title":"Biochim Biophys Acta (BBA) Mol Cell Res"},{"key":"9383_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.aca.2013.03.023","volume":"776","author":"AL Capriotti","year":"2013","unstructured":"Capriotti AL, Caruso G, Cavaliere C, Piovesana S, Samperi R, Lagan\u00e0 A (2013) Proteomic characterization of human platelet-derived microparticles. Anal Chim Acta 776:57\u201363. https:\/\/doi.org\/10.1016\/j.aca.2013.03.023","journal-title":"Anal Chim Acta"},{"issue":"5","key":"9383_CR29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood-2016-11-751099","volume":"130","author":"JV Michael","year":"2017","unstructured":"Michael JV, Wurtzel JGT, Mao GF, Rao AK, Kolpakov MA, Sabri A et al (2017) Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth. Blood 130(5):567\u2013580. https:\/\/doi.org\/10.1182\/blood-2016-11-751099","journal-title":"Blood"},{"key":"9383_CR30","doi-asserted-by":"publisher","first-page":"1207361","DOI":"10.3389\/fimmu.2023.1207631","volume":"14","author":"E Gharib","year":"2023","unstructured":"Gharib E, Veilleux V, Boudreau LH, Pichaud N, Robichaud GA (2023) Platelet-derived microparticles provoke chronic lymphocytic leukemia malignancy through metabolic reprogramming. Front Immunol 14:1207361. https:\/\/doi.org\/10.3389\/fimmu.2023.1207631","journal-title":"Front Immunol"},{"issue":"8","key":"9383_CR31","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.3390\/cancers13081870","volume":"13","author":"D Cacic","year":"2021","unstructured":"Cacic D, Reikvam H, Nordg\u00e5rd O, Meyer P, Hervig T (2021) Platelet microparticles protect acute myelogenous leukemia cells against daunorubicin-induced apoptosis. Cancers [Internet] 13(8):1870","journal-title":"Cancers [Internet]"},{"issue":"1","key":"9383_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4049\/jimmunol.1301790","volume":"192","author":"Y Pan","year":"2014","unstructured":"Pan Y, Liang H, Liu H, Li D, Chen X, Li L et al (2014) Platelet-secreted MicroRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. J Immunol 192(1):437\u2013446. https:\/\/doi.org\/10.4049\/jimmunol.1301790","journal-title":"J Immunol"},{"issue":"6","key":"9383_CR33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.4252\/wjsc.v12.i6.481","volume":"12","author":"BD Xiao","year":"2020","unstructured":"Xiao BD, Zhao YJ, Jia XY, Wu J, Wang YG, Huang F (2020) Multifaceted p21 in carcinogenesis, stemness of tumor and tumor therapy. World J Stem Cells 12(6):481\u2013487. https:\/\/doi.org\/10.4252\/wjsc.v12.i6.481","journal-title":"World J Stem Cells"},{"key":"9383_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ceb.2017.11.005","volume":"51","author":"SS Mello","year":"2018","unstructured":"Mello SS, Attardi LD (2018) Deciphering p53 signaling in tumor suppression. Curr Opin Cell Biol 51:65\u201372. https:\/\/doi.org\/10.1016\/j.ceb.2017.11.005","journal-title":"Curr Opin Cell Biol"},{"issue":"7","key":"9383_CR35","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/09537104.2022.2027903","volume":"33","author":"MEW Collier","year":"2022","unstructured":"Collier MEW, Ambrose AR, Goodall AH (2022) Does hsa-miR-223-3p from platelet-derived extracellular vesicles regulate tissue factor expression in monocytic cells? Platelets 33(7):1031\u20131042. https:\/\/doi.org\/10.1080\/09537104.2022.2027903","journal-title":"Platelets"},{"key":"9383_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.658524","volume":"12","author":"B Szil\u00e1gyi","year":"2021","unstructured":"Szil\u00e1gyi B, Fejes Z, Ruszny\u00e1k \u00c1, Fenyvesi F, P\u00f3csi M, Halmi S et al (2021) Platelet microparticles enriched in miR-223 reduce ICAM-1-dependent vascular inflammation in septic conditions. Front Physiol 12:658524. https:\/\/doi.org\/10.3389\/fphys.2021.658524","journal-title":"Front Physiol"},{"issue":"4","key":"9383_CR37","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.3892\/mmr.2018.8492","volume":"17","author":"B Lu","year":"2018","unstructured":"Lu B, Christensen IT, Ma LW, Wang XL, Jiang LF, Wang CX et al (2018) miR-24-p53 pathway evoked by oxidative stress promotes lens epithelial cell apoptosis in age-related cataracts. Mol Med Rep 17(4):5021\u20135028. https:\/\/doi.org\/10.3892\/mmr.2018.8492","journal-title":"Mol Med Rep"},{"issue":"8","key":"9383_CR38","doi-asserted-by":"publisher","first-page":"607","DOI":"10.34172\/aim.2021.86","volume":"24","author":"MSS Pour","year":"2021","unstructured":"Pour MSS, Kasgari FH, Farsinejad A, Fatemi A, Hassanshahi G, Khalilabadi RM (2021) Platelet microparticles accelerate proliferation and growth of mesenchymal stem cells through longevity-related genes. Arch Iran Med 24(8):607\u2013614. https:\/\/doi.org\/10.34172\/aim.2021.86","journal-title":"Arch Iran Med"},{"issue":"4","key":"9383_CR39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/onc.2010.425","volume":"30","author":"G Sommer","year":"2011","unstructured":"Sommer G, Dittmann J, Kuehnert J, Reumann K, Schwartz PE, Will H et al (2011) The RNA-binding protein La contributes to cell proliferation and CCND1 expression. Oncogene 30(4):434\u2013444. https:\/\/doi.org\/10.1038\/onc.2010.425","journal-title":"Oncogene"},{"issue":"12","key":"9383_CR40","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1080\/10428190400003317","volume":"45","author":"J-H Liu","year":"2004","unstructured":"Liu J-H, Yen C-C, Lin Y-C, Gau J-P, Yang M-H, Chao T-C et al (2004) Overexpression of cyclin D1 in accelerated-phase chronic myeloid leukemia. Leuk Lymphoma 45(12):2419\u20132425. https:\/\/doi.org\/10.1080\/10428190400003317","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"9383_CR41","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0301-472X(02)00791-9","volume":"30","author":"M Baj-Krzyworzeka","year":"2002","unstructured":"Baj-Krzyworzeka M, Majka M, Pratico D, Ratajczak J, Vilaire G, Kijowski J et al (2002) Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 30(5):450\u2013459. https:\/\/doi.org\/10.1016\/S0301-472X(02)00791-9","journal-title":"Exp Hematol"},{"issue":"1","key":"9383_CR42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.22074\/cellj.2018.5032","volume":"20","author":"M Yaftian","year":"2018","unstructured":"Yaftian M, Yari F, Ghasemzadeh M, Fallah Azad V, Haghighi M (2018) Induction of apoptosis in cancer cells of pre-B ALL patients after exposure to platelets, platelet-derived microparticles and soluble CD40 ligand. Cell J 20(1):120\u2013126. https:\/\/doi.org\/10.22074\/cellj.2018.5032","journal-title":"Cell J"},{"issue":"1","key":"9383_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12307-014-0149-3","volume":"7","author":"J Velez","year":"2014","unstructured":"Velez J, Enciso LJ, Suarez M, Fiegl M, Grismaldo A, L\u00f3pez C et al (2014) Platelets promote mitochondrial uncoupling and resistance to apoptosis in leukemia cells: a novel paradigm for the bone marrow microenvironment. Cancer Microenviron 7(1):79\u201390. https:\/\/doi.org\/10.1007\/s12307-014-0149-3","journal-title":"Cancer Microenviron"},{"issue":"2","key":"9383_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bbamcr.2003.10.014","volume":"1644","author":"N Bonnefoy-Berard","year":"2004","unstructured":"Bonnefoy-Berard N, Aouacheria A, Verschelde C, Quemeneur L, Marais A, Marvel J (2004) Control of proliferation by Bcl-2 family members. Biochim Biophys Acta (BBA) Mol Cell Res 1644(2):159\u201368. https:\/\/doi.org\/10.1016\/j.bbamcr.2003.10.014","journal-title":"Biochim Biophys Acta (BBA) Mol Cell Res"},{"issue":"1","key":"9383_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.34172\/apb.2021.005","volume":"11","author":"M Nazari","year":"2021","unstructured":"Nazari M, Javandoost E, Talebi M, Movassaghpour A, Soleimani M (2021) Platelet microparticle controversial role in cancer. Adv Pharm Bull 11(1):39\u201355. https:\/\/doi.org\/10.34172\/apb.2021.005","journal-title":"Adv Pharm Bull"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09383-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09383-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09383-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T03:14:57Z","timestamp":1738725297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09383-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9383"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09383-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2024,5,25]]},"assertion":[{"value":"11 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Vice Chancellor for Research and Technology of Kerman University of Medical Sciences (IR.KMU.REC.1399.420).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study. I pledge and declare that I will voluntarily donate my blood to needy patients after studying, clearing doubts, and gaining knowledge about diseases transmitted by blood transfusion (such as hepatitis, syphilis, AIDS, etc.), and honestly answering any questions. I have been informed by the attending doctor about potential adverse reactions caused by blood donation, as well as the care procedures, complications, and tests that will be conducted on my blood. I agree that if the test results on my donated sample are positive, they will be kept confidential and reported to the Ministry of Health to receive health services. Furthermore, to contribute to national health improvement, I authorize the use of my blood and samples for research purposes. I consent to the registration of my information in the Blood Transfusion Organization software without hindrance, and I hereby grant the Blood Transfusion Organization access to the aforementioned information for my future referrals to the organization for blood donation or other purposes. Moreover, I will promptly inform the organization if I experience any symptoms related to the donation by calling the provided phone number.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"676"}}